Hadley Ford is a healthcare and technology industry veteran with more than 30 years of experience as both an operating executive, investor and investment banker. Mr. Ford has extensive experience in all operational facets of managing a large, world-class patient-centric healthcare operation. Prior to iAnthus, Mr. Ford was the co-founder and CEO of ProCure Treatment Centers, Inc., the world's leading developer and operator of full-service proton therapy centers for the treatment of cancer. Prior to ProCure, Mr. Ford spent sixteen years on Wall Street with Fidelity, First Boston, Bank of America and Goldman Sachs, where he completed over 150 transactions worth over $50 billion for all size clients in multiple industries.

Randy Maslow is a veteran tech industry attorney and entrepreneur, with more than 30 years' experience as a senior executive and General Counsel to rapidly growing companies in emerging industries. Mr. Maslow was Executive Vice President and General Counsel at one of the first online travel companies before joining the founding management team of the early nationwide internet service provider that became XO Communications, Inc., where he served as Senior Vice President for Business Development and General Counsel and as a board member. Mr. Maslow later co-founded Internet Gaming Entertainment U.S. ("IGE"), where he served as Senior Vice President and General Counsel and as a board member. IGE pioneered the currency exchange business for virtual assets in multi-player online games and became a leading worldwide publisher of multi-player computer game content, with 400 employees in the U.S. and Asia and over $100 million in annual revenue. Prior to entering the tech industry, Mr. Maslow was an attorney in private practice with Greenberg Traurig LLP in Florida, and previously with the Philadelphia law firms White and Williams LLP and Blank Rome LLP.

Mr. Maslow is a member of the Federal Policy Council of the National Cannabis Industry Association, the Board of Directors of the Cannabis Trade Federation, and the Board of Trustees of the New Jersey Cannabis Industry Association, as well as a member of the Massachusetts Responsible Regulation Alliance and the New York Medical Cannabis Industry Association.

Beth Stavola is a leading cannabis entrepreneur. Former COO, President of US Operations, and Board Member of MPX Bioceutical Corporation. Also, founder of Health for Life, one of the most recognized cannabis brands in Arizona, which she took from inception to significant sales and cash flow in just five years. In addition, she is the founder of Melting Point Extracts (MPX), an award-winning maker of high quality cannabis concentrates.

In February 2016, Ms. Stavola launched CBD for Life, a company that produces highly innovative, natural and effective CBD-infused pain management and beauty products using 99% pure CBD extract. The product has met with rave reviews from prominent beauty publications and bloggers, as well as client testimonials.

Previously, Ms. Stavola worked on Wall Street with Jefferies and Company, rising to the position of senior vice president. She is actively involved in organizations that promote women in the cannabis industry and in 2014 was named as one of the leading medical cannabis entrepreneurs by Congresswoman Dina Titus, on the floor of the House of Representatives.

Mr. Kalcevich has over 15 years of experience in corporate finance and strategic consulting. Previously a partner of BG Partners Corp. in Toronto, Canada, he was responsible for planning, structuring and monitoring corporate finance transactions for his firm's cannabis investments. Mr. Kalcevich was previously a Director of Investment Banking with CIBC World Markets and Oppenheimer in Toronto and New York. During the period of 2005-2012, he completed over 20 transactions representing over $4 billion in aggregate value.

Paul Rosen is a founder of PharmaCan Capital Corporation, a publicly traded merchant bank focused on investing in Canada's medical marijuana industry. Mr. Rosen served as President and CEO of PharmaCan Capital for three years. While CEO at PharmaCan, Mr. Rosen executed the successful purchase of In The Zone Produce Ltd ("ITZ"), a Canadian medical marijuana producer licensed by Health Canada following which he concurrently served as President and the Senior Person in Charge (SPIC) at ITZ. An SPIC is the executive required by Health Canada to exercise overall responsibility for management of all regulated activities carried out by the licensed producer at its site. Prior to founding PharmaCan, Mr. Rosen founded and served as CEO of Skypad Inc. ("Skypad"), a leading global contract manufacturer. Mr. Rosen currently serves as Skypad's Chairman.

Mr. Petch has 30 + years of senior management, strategic planning and financial analysis experience, including both buy-side and sell-side capital markets experience. He spent fifteen years at Dresdner Kleinwort Benson advising companies on strategy and fundraising, including leading a number of successful IPOs, acquisitions and disposals. Mr. Petch is a Chartered Accountant, and has an honours degree in Engineering Science from Oxford University.

Robert Galvin was most recently CFO and Senior VP of Finance and Administration at Holtec International, an energy technology company. Prior to joining Holtec, he served as CFO of several companies, including NuCO2, a NASDAQ company providing bulk CO2 equipment and services. Mr. Galvin is experienced with mergers & acquisitions, debt and equity financings, and SEC compliance. He is a CPA, a Director, and Audit Chair for OneSource Water, and a Director and former Stewardship Chair for the New Jersey Juvenile Diabetes Research Foundation.